Leonardo dos Reis Silveira

Dr. Leonardo dos Reis Silveira


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2012 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
AMAmanda R Martins
Amanda R Martins
RNRenato Nachbar
Renato Nachbar
RGRenata Gorjao
Renata Gorjao
MVMarco Aurélio Vinolo
Marco Aurélio Vinolo
WFWilliam Festuccia
William Festuccia
SHSandro Massao Hirabara
Sandro Massao Hirabara
Insulin resistance condition is associated to the development of several syndromes, such as obesity, type 2 diabetes mellitus and metabolic syndrome. Although the factors linking insulin resistance to these syndromes are not precisely defined yet, evidence suggests that the elevated plasma free fatty acid (FFA) level plays an important role in the development of skeletal muscle insulin resistance. Accordantly, in vivo and in vitro exposure of skeletal muscle and myocytes to physiological concentrations of saturated fatty acids is associated with insulin resistance condition. Several mechanisms have been postulated to account for fatty acids-induced muscle insulin resistance, including Randle cycle, oxidative stress, inflammation and mitochondrial dysfunction. Here we reviewed experimental evidence supporting the involvement of each of these propositions in the development of skeletal muscle insulin resistance induced by saturated fatty acids and propose an integrative model placing mitochondrial dysfunction as an important and common factor to the other mechanisms.

1 September 2003 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
LSLeonardo dos Reis Silveira
Leonardo dos Reis Silveira
LPLucia Pereira-Da-Silva
Lucia Pereira-Da-Silva
CJCarsten Juel
Carsten Juel
YHYlva Hellsten
Ylva Hellsten

29 April 2008 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
RLRafael Herling Lambertucci
Rafael Herling Lambertucci
SHSandro Massao Hirabara
Sandro Massao Hirabara
LSLeonardo dos Reis Silveira
Leonardo dos Reis Silveira
ALAdriana Cristina Levada‐Pires
Adriana Cristina Levada‐Pires
RCRui Curi
Rui Curi
TPTania Cristina Pithon‐Curi
Tania Cristina Pithon‐Curi


1 July 2014 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
BTBruno G. Teodoro
Bruno G. Teodoro
FBFlavia G. Baraldi
Flavia G. Baraldi
ISIgor H. Sampaio
Igor H. Sampaio
LBLucas H. M. Bomfim
Lucas H. M. Bomfim
AQAndré L. Queiroz
André L. Queiroz
EVElaine Vieira
Elaine Vieira

1 June 2014 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
RLRheure Alves Moreira Lopes
Rheure Alves Moreira Lopes
KNKarla Neves
Karla Neves
CPCezar Rangel Pestana
Cezar Rangel Pestana
AQAndré Lima Queiroz
André Lima Queiroz
CZCamila Ziliotto Zanotto
Camila Ziliotto Zanotto
RTRita de Cássia Tostes
Rita de Cássia Tostes
Testosterone exerts both beneficial and harmful effects on the cardiovascular system. Considering that testosterone induces reactive oxygen species (ROS) generation and ROS activate cell death signaling pathways, we tested the hypothesis that testosterone induces apoptosis in vascular smooth muscle cells (VSMCs) via mitochondria-dependent ROS generation. Potential mechanisms were addressed. Cultured VSMCs were stimulated with testosterone (10−7mol/l) or vehicle (2–12 h) in the presence of flutamide (10−5mol/l), CCCP (10−6mol/l), mimetic manganese(III) tetrakis(1-methyl-4-pyridyl)porphyrin (MnTMPyP; 3 × 10−5mol/l), Z-Ile-Glu(O-ME)-Thr-Asp(O-Me) fluoromethyl ketone (Z-IETD-FMK; 10−5mol/l), or vehicle. ROS were determined with lucigenin and dichlorodihydrofluorescein; apoptosis, with annexin V and calcein; O2consumption, with a Clark-type electrode, and procaspases, caspases, cytochrome c, Bax, and Bcl-2 levels by immunoblotting. Testosterone induced ROS generation (relative light units/mg protein, 2 h; 162.6 ± 16 vs. 100) and procaspase-3 activation [arbitrary units, (AU), 6 h; 166.2 ± 19 vs. 100]. CCCP, MnTMPyP, and flutamide abolished these effects. Testosterone increased annexin-V fluorescence (AU, 197.6 ± 21.5 vs. 100) and decreased calcein fluorescence (AU, 34.4 ± 6.4 vs. 100), and O2consumption (nmol O2/min, 18.6 ± 2.0 vs. 34.4 ± 3.9). Testosterone also reduced Bax-to-Bcl-2 ratio but not cytochrome- c release from mitochondria. Moreover, testosterone (6 h) induced cleavage of procaspase 8 (AU, 161.1 ± 13.5 vs. 100) and increased gene expression of Fas ligand (2ΔΔCt, 3.6 ± 1.2 vs. 0.7 ± 0.5), and TNF-α (1.7 ± 0.4 vs. 0.3 ± 0.1). CCCP, MnTMPyP, and flutamide abolished these effects. These data indicate that testosterone induces apoptosis in VSMCs via the extrinsic apoptotic pathway with the involvement of androgen receptor activation and mitochondria-generated ROS.